These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1569 related articles for article (PubMed ID: 32746880)
1. Dendritic cell biology and its role in tumor immunotherapy. Wang Y; Xiang Y; Xin VW; Wang XW; Peng XC; Liu XQ; Wang D; Li N; Cheng JT; Lyv YN; Cui SZ; Ma Z; Zhang Q; Xin HW J Hematol Oncol; 2020 Aug; 13(1):107. PubMed ID: 32746880 [TBL] [Abstract][Full Text] [Related]
2. Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses. Silva M; Silva Z; Marques G; Ferro T; Gonçalves M; Monteiro M; van Vliet SJ; Mohr E; Lino AC; Fernandes AR; Lima FA; van Kooyk Y; Matos T; Tadokoro CE; Videira PA Oncotarget; 2016 Jul; 7(27):41053-41066. PubMed ID: 27203391 [TBL] [Abstract][Full Text] [Related]
3. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network. Bodey B; Bodey B; Kaiser HE In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303 [TBL] [Abstract][Full Text] [Related]
4. Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses. Nouri-Shirazi M; Banchereau J; Bell D; Burkeholder S; Kraus ET; Davoust J; Palucka KA J Immunol; 2000 Oct; 165(7):3797-803. PubMed ID: 11034385 [TBL] [Abstract][Full Text] [Related]
5. Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation. Birkholz K; Schwenkert M; Kellner C; Gross S; Fey G; Schuler-Thurner B; Schuler G; Schaft N; Dörrie J Blood; 2010 Sep; 116(13):2277-85. PubMed ID: 20566893 [TBL] [Abstract][Full Text] [Related]
6. Exosomes as a tumor vaccine: enhancing potency through direct loading of antigenic peptides. Hsu DH; Paz P; Villaflor G; Rivas A; Mehta-Damani A; Angevin E; Zitvogel L; Le Pecq JB J Immunother; 2003; 26(5):440-50. PubMed ID: 12973033 [TBL] [Abstract][Full Text] [Related]
7. Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery. Schnurr M; Chen Q; Shin A; Chen W; Toy T; Jenderek C; Green S; Miloradovic L; Drane D; Davis ID; Villadangos J; Shortman K; Maraskovsky E; Cebon J Blood; 2005 Mar; 105(6):2465-72. PubMed ID: 15546948 [TBL] [Abstract][Full Text] [Related]
8. [Development of effective antigen delivery carrier to dendritic cells via Fc receptor in cancer immunotherapy]. Suzuki R; Utoguchi N; Kawamura K; Kadowaki N; Okada N; Takizawa T; Uchiyama T; Maruyama K Yakugaku Zasshi; 2007 Feb; 127(2):301-6. PubMed ID: 17268150 [TBL] [Abstract][Full Text] [Related]
9. Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8(+) and CD4(+) T Cells. Yin W; Gorvel L; Zurawski S; Li D; Ni L; Duluc D; Upchurch K; Kim J; Gu C; Ouedraogo R; Wang Z; Xue Y; Joo H; Gorvel JP; Zurawski G; Oh S EBioMedicine; 2016 Mar; 5():46-58. PubMed ID: 27077111 [TBL] [Abstract][Full Text] [Related]
11. Acquisition and Presentation of Tumor Antigens by Dendritic Cells. Bonaccorsi I; Campana S; Morandi B; Ferlazzo G Crit Rev Immunol; 2015; 35(5):349-64. PubMed ID: 26853848 [TBL] [Abstract][Full Text] [Related]
12. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. André F; Chaput N; Schartz NE; Flament C; Aubert N; Bernard J; Lemonnier F; Raposo G; Escudier B; Hsu DH; Tursz T; Amigorena S; Angevin E; Zitvogel L J Immunol; 2004 Feb; 172(4):2126-36. PubMed ID: 14764678 [TBL] [Abstract][Full Text] [Related]
13. Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II molecules. Parkhurst MR; DePan C; Riley JP; Rosenberg SA; Shu S J Immunol; 2003 May; 170(10):5317-25. PubMed ID: 12734382 [TBL] [Abstract][Full Text] [Related]
14. Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells. Adams EW; Ratner DM; Seeberger PH; Hacohen N Chembiochem; 2008 Jan; 9(2):294-303. PubMed ID: 18186095 [TBL] [Abstract][Full Text] [Related]
15. Type I interferon activates MHC class I-dressed CD11b Duong E; Fessenden TB; Lutz E; Dinter T; Yim L; Blatt S; Bhutkar A; Wittrup KD; Spranger S Immunity; 2022 Feb; 55(2):308-323.e9. PubMed ID: 34800368 [TBL] [Abstract][Full Text] [Related]